Selected article for: "acute respiratory sars syndrome coronavirus and liver enzyme"
Author: Drăgănescu, Anca Cristina; Săndulescu, Oana; Bilașco, Anuța; Kouris, Camelia; Streinu-Cercel, Anca; Luminos, Monica; Streinu-Cercel, Adrian
Title: Transient immune hepatitis as post-coronavirus disease complication: A case report
  • Cord-id: 35a30lc6
  • Document date: 2021_6_6
    • ID: 35a30lc6
    Snippet: BACKGROUND: We report a case of post-coronavirus disease (COVID) immune hepatitis occurring in a young male with no pre-existing comorbidities. CASE SUMMARY: A previously healthy 21-year-old male patient was admitted to our hospital with mild COVID-19. During the course of in-hospital isolation and monitoring, he developed an alanine aminotransferase (ALT) and aspartate aminotransferase (AST) increase, with the enzymes peaking at day 24 (ALT 15 times the upper normal limit), with preserved liver
    Document: BACKGROUND: We report a case of post-coronavirus disease (COVID) immune hepatitis occurring in a young male with no pre-existing comorbidities. CASE SUMMARY: A previously healthy 21-year-old male patient was admitted to our hospital with mild COVID-19. During the course of in-hospital isolation and monitoring, he developed an alanine aminotransferase (ALT) and aspartate aminotransferase (AST) increase, with the enzymes peaking at day 24 (ALT 15 times the upper normal limit), with preserved liver function. The liver enzyme increase occurred 20 d after the complete clinical remission of COVID-19, and ALT dynamics paralleled the increase in total antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The case was interpreted as post-COVID immune hepatitis, with extensive laboratory investigations excluding other potential causes. The hepatocytolysis remitted 20 d after the peak ALT, without further intervention, with complete recovery, but the total anti-SARS-CoV-2 antibodies continued to increase the next 5 mo following the acute infection. CONCLUSION: Close attention should also be paid to young patients with mild forms of disease, and a high index of suspicion should be maintained for post-COVID complications.

    Search related documents:
    Co phrase search for related documents
    • abnormal liver function test and liver affect: 1
    • abnormal liver function test and liver enzyme: 1
    • abnormal liver function test and liver failure: 1
    • abnormal liver function test and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal liver function test and liver function test: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal liver function test and liver function test normal: 1
    • abnormal liver function test and liver injury: 1, 2
    • acute disease and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute disease and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
    • acute disease and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and liver function test: 1, 2, 3, 4
    • acute disease and liver function test normal: 1, 2
    • acute disease and liver inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute disease and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and long term consequence: 1, 2, 3
    • acute disease and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute disease and low molecular weight heparin thromboprophylaxis: 1, 2
    • acute disease and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25